Breast Cancer in Young Women Conference - OECI

ESO INSIDE TRACK CONFERENCE
Breast Cancer in
Young Women
Conference
8-10 November 2012
Dublin, Ireland
In collaboration with
Chairs:
F. Cardoso, PT - B. Kaufman, IL
A. Partridge, US
Host-Chair: J. Geraghty, IE
Scientific Committee: S. Aebi, CH - H.A. Azim Jr, BE
G. Freilich, UK - M.C. King, US
F.A. Peccatori, IT
In association with
SECOND ANNOUNCEMENT

FOREWORD
Breast cancer in young women is a devastating and
complex disease. Breast cancer in women under 40
strikes when these women are at the peak of their
reproductive years, family life and careers and still have
many years ahead of them to suffer the long-term effects
of treatment or the consequences of recurrent disease.
The etiology of breast cancer in this population is poorly
understood and most clinical trials focus on women who
are over the age of 40, thus little evidence-based data
is available about the optimal management of these
patients. Further research is much needed in this field.
This conference is an opportunity for the latest updates
on this field and a platform for generating future research
concepts and collaborations. It will cover epidemiology,
molecular biology, genetics, pathology, surgery,
radiotherapy, systemic therapy and fertility preservation in
young women with breast cancer.
We hope that you will join us and contribute to further
develop the understanding and treatment of this disease.
On behalf of the Chairs and Scientific Committee
Members
Bella Kaufman
:: 2 ::

LEARNING OBJECTIVES
In depth learning of various aspects of breast cancer in young women
Importance of multi-disciplinary management
Management of difficult clinical cases
MAIN TOPICS
Hereditary breast cancer
Diagnostic tools in young women
Local therapy
Systemic therapy
Pregnancy and breast cancer
Fertility preservation
Psychosocial aspects
Management of side effects
Case discussions
PARTICIPANT’S PROFILE
Medical oncologists
Surgeons
Gynaecologists
Radiation oncologists
Onco-geneticists
Pathologists
Nurses
Patient advocates
:: 3 ::

FACULTY
O. Abulkhair, King Abdulaziz Medical City for National Guard, Riyadh, SA
S. Aebi, Luzerner Kantonsspital, Lucerne, CH
F. Amant, U.Z Gasthuisberg, Leuven, BE
C. Anders, UNC Linenberger Comprehensive Cancer Center, Chapel Hill, US
J. Armstrong, St. Luke’s Institute of Cancer Research, Dublin, IE
A.G. Arnold, Memorial Sloan-Kettering Cancer Center, New York, US
H.A. Azim Jr., Jules Bordet Institute, Brussels, BE
F.A. Calvo, Hospital General Universitario Gregorio Marañon, Madrid, ES
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
A.M. Cluxton, Young Survival Coalition, Columbus, US
R.E. Coleman, Weston Park Hospital, Sheffield, UK
M. Colleoni, European Institute of Oncology, Milan, IT
E. Connolly, St. James Hospital, Dublin, IE
A. Costa, European School of Oncology, Milan, IT
J. Crown, NICB Dublin City University, Dublin, IE
S. Delaloge, Institut Gustave Roussy, Villejuif, FR
J. Dix, Adoption Consultant, Isle of Wight, UK
G. Freilich, Europa Donna, London, UK
E. Furlong, University College Dublin, Dublin, IE
T. Gagliardi, Aberdeen Royal Infirmary, Foresterhill Aberdeen, UK
J. Garber, Dana Farber Cancer Institute, Boston, US
O.D. Gentilini, European Institute of Oncology, Milan, IT
J. Geraghty, St Vincent’s Hospital, Dublin, IE
A. Graziottin, Saint Raffaele Resnati Hospital, Milan, IT
A. Green, School of Medicine & Medical Science, Dublin, IE
N. Harbeck, Breast Center, University of Munich, DE
B. Kaufman, Sheba Medical Center, Tel Hashomer, IL
M. Kell, University College Dublin, Dublin, IE
C. Kelly, Mater Misericordiae Hospital, Dublin, IE
J. King, Royal Free Hampstead NHS Trust, London, UK
M.C. King, University of Washington - School of Medicine, Seattle, US
C.K. Kuhl, Aachen University Clinic, Aachen, DE
S. Loibl, German Breast Group, Neu-Isenburg, DE
E.W. McDermott, St. Vincent Hospital, Dublin, IE
D. Meirow, Sheba Medical Center, Tel Aviv, IL
E. Mocanu, Rotunda Maternity Hospital, Dublin, IE
A. O’Doherty, National Cancer Screening Service, Dublin, IE
G. O’Dowd, Irish Cancer Society, Dublin, IE
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Paluch-Shimon, Sheba Medical Center, Tel Hashomer, IL
A.H. Partridge, Dana-Farber Cancer Institute, Boston, US
F.A. Peccatori, European Institute of Oncology, Milan, IT
I. Smith, Royal Marsden Hospital, Sutton Surrey-London, UK
A. Tutt, Kings College London School of Medicine, Guy’s Hospital Camp, London, UK
:: 4 ::

PROGRAMME
THURSDAY, 8 NOVEMBER
13:30 Christine Murphy Whyte memorial lecture Chair: J. Geraghty, IE
13:40 Presentation for a Young Irish Patient G. O’Dowd, IE
13:55 Presentation from the Young Survival Coalition A. Cluxton, US
14:10 Breast Cancer in Young Women:
the magnitude of the problem
B. Kaufman, IL
14:25 SESSION I:
Debate: The biology of breast cancer in young women is unique
14:25 Introduction by Chair J. Garber, US
14:30 In favour M. Colleoni, IT
14:50 Against C. Anders, US
15:10 Coffee break
15:40 SESSION II: Familial and hereditary breast cancer Chair: A. Green, IE
15:40 Biology of BRCA - associated breast cancer A. Tutt, UK
16:00 Genetic counselling and testing A.G. Arnold, US
16:20 Cancer risk-reducing measures for high risk women J. Garber, US
16:45 The woman’s perspective G. Freilich, UK
17:00 Best Abstracs presentations Chairs: E. Connolly, IE
and M. Kell, IE
17:30 Case discussion session 1 Moderators: B. Kaufman, IL
Panel: Speakers and Chairs
and S. Paluch-Shimon, IL
18:10-19:10 Satellite symposium
:: 5 ::

FRIDAY, 9 NOVEMBER
9:00 SESSION III: Staging of breast cancer in young women Chair: A. O’Doherty, IE
9:00 How to best use available techniques C.K. Kuhl, DE
9:20 Emerging technologies T. Gagliardi, UK
9:40 SESSION IV:
Loco-regional therapy. What should be different
in young women
Chairs: A. Costa, IT
and J. Armstrong, IE
9:40 Surgery O.D. Gentilini, IT
10:00 Radiotherapy F.A. Calvo, ES
10:20 Coffee break
11:00 SESSION V: Adjuvant systemic therapy Chairs: N. Harbeck, DE
and A.H. Partridge, US
11:00 Endocrine therapy for early breast cancer: standards
and controversies
O. Pagani, CH
11:25 Debate: All young early breast cancer patients should
receive adjuvant chemotherapy
11:25 Introduction by Chair S. Aebi, CH
11:30 In favour F.A. Peccatori, IT
11:50 Against S. Delaloge, FR
12:10 Adjuvant bisphosphonates for young early
breast cancer patients
12:10 Bisphosphonates in the adjuvant setting:
ready for prime time?
12:35 RANKL signalling: bone metastasis
and beyond
Chair: J. Crown, IE
I. Smith, UK
R.E. Coleman, UK
13:00 Lunch and poster session
:: 6 ::

14:30 SESSION VI: Advanced breast cancer Chair: S. Aebi, CH
14:30 Advanced breast cancer in young women:
what should be different
F. Cardoso, PT
14:55 Advances in targeted therapy N. Harbeck, DE
15:15 Case discussion session II Moderators: A.H. Partridge, US
Panel: Speakers from and Chairs from sessions V and VI
and O. Abulkhair, SA
16:00 Coffee break
16:30 SESSION VII: Fertility and adoption Chairs: E.W. McDermott, IE
and E. Mocanu, IE
16:30 Fertility preservation D. Meirow, IL
16:55 Can I adopt a child? J. Dix, UK
17:10-18:40 Satellite symposium
:: 7 ::

SATURDAY, 10 NOVEMBER
8:30 SESSION VIII: Quality of life issues Chairs: A. Costa, IT
and J. King, UK
8:30 Management of early menopause associated symptoms A. Partridge, US
8:55 The young couple and breast cancer A. Graziottin, IT
9:15 “Mommy has breast cancer”: how do the children cope? E. Furlong, IE
9:30 SESSION IX: Breast cancer and pregnancy Chair: F. Cardoso, PT
and C. Kelly, IE
9:30 Breast cancer during pregnancy:
the oncologist perspective
S. Loibl, DE
9:50 Breast Cancer during pregnancy:
the obstetrician/paediatric perspective
F. Amant, BE
10:10 Pregnancy after breast cancer H.A. Azim Jr, BE
10:25 Pregnancy registry and trial project O. Pagani, CH
10:35 Coffee break
11:00 Case discussion session III Moderators: F.A. Peccatori, IT
Panel: Speakers, Chairs and patient representative
and C. Kelly, IE
11:40 SESSION X:
Breast Cancer in Young Women Conference Statement
Chairs: B. Kaufman, IL
A.H. Partridge, US and
F. Cardoso, PT
Panel: S. Aebi, CH - F. Amant, BE - H.A. Azim Jr, BE - F.A. Calvo, ES - S. Delaloge, FR
G. Freilich, UK - T. Gagliardi, UK - J. Garber, US - O.D. Gentilini, IT - N. Harbeck, DE
C.K. Kuhl, DE - S. Loibl, DE - D. Meirow, IL - O. Pagani, CH - F.A. Peccatori, IT
13:10 Closing remarks J. Geraghty, IE
:: 8 ::

GENERAL INFORMATION
ORGANISING SECRETARIAT
Francesca Marangoni - fmarangoni@eso.net
Tel: +39 02 85464525
Roberta Ventura - rventura@eso.net
Tel: +39 02 85464532
European School of Oncology
Via del Bollo, 4
20123 Milan, Italy
Fax: +39 02 85464545
VENUE
O’Reilly Hall
University College Dublin
Belfield, Dublin 4 - Ireland
Map available here:
www.ucd.ie/maps/UCD_Map_July_2011.pdf
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
BADGE
The badge is the only official evidence of registration and should be worn at all times during
the conference. Loss of badge means loss of registration.
INSURANCE
The organizers bear no responsibility for untoward events in relation to the participation in the
Convention. Participants are advised to take out their own personal and travel insurance
coverage.
ABSTRACT BOOK
An abstract book will be published as supplement to The Breast and will contain abstracts of
the invited lecturers and those submitted by the participants that have been accepted for oral
or poster presentation or for publication only. The three best abstracts will be selected and
proposed for oral presentation (Free registration will be granted to the first author of the three
selected abstracts). Oral presentations will be scheduled on 8 November and poster session
will be scheduled on 9 November.
Online submission and information available on www.eso.net.
CME ACCREDITATION AND CERTIFICATES
Participants will be issued a certificate of attendance.
Application for CME recognition has been submitted to ESMO for ESMO-MORA accreditation,
to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation
Council for Continuing Medical Education (EACCME), an institution of the European Union of
Medical Specialists (UEMS). The event was granted 12 European CME credits (ECMEC) by the
European Accreditation Council for Continuing Medical Education (EACCME).
EACCME credits are recognized by the American Medical Association towards the Physician’s
Recognition Award (PRA).
The programme was furthermore awarded with 14 cat. 1 ESMO-MORA points.
:: 9 ::

GENERAL INFORMATION
NURSES AND PATIENT ADVOCATES
Nurses and representatives of cancer patient advocacy non-profit organizations are eligible for
a discounted registration fee:
EUR 180 by 5 August, EUR 230 by 14 October, EUR 280 after 14 October and onsite.
Interested nurses and patient advocates should contact Roberta Ventura (rventura@eso.net)
in order to register to the conference.
TRAVEL GRANTS
Thanks to the generosity of BCY1 sponsors travel grants are made available on a competitive
basis to:
n Physicians from middle- and low-income countries as defined by The World Bank;
n Physicians under the age of 40;
n Nurses;
n Patient Advocates.
Full applications should be submitted by 1 July to Roberta Ventura (rventura@eso.net) and
include:
n Curriculum vitae including full affiliation, contact details and date of birth;
n Letter describing motivation for attending;
n Physicians and nurses are furthermore asked to submit a letter of endorsement by the
Institute/Department director or head nurse;
n The successful submission of an abstract (deadline 1 July) is not mandatory but would be
considered in the selection process.
Travel grant recipients will receive a set amount to contribute to their travel and
accommodation expenses, whilst registration will be processed directly by ESO free of charge.
The following amounts will be refunded by bank transfer after the conference: EUR 500 for
participants coming from Europe, Middle-East and North-Africa; EUR 1.000 for participants
coming from other regions and overseas. The outcome of the application will be notified by
27 July.
PASSPORT AND VISA
A valid passport and/or identity card is required for entry into Dublin. A visa may be required
for some countries. For specific information, please visit the department of Foreign affairs and
Trade website at www.dfa.ie.
SPONSORSHIP OPPORTUNITIES
The Invitation to Sponsors can be downloaded at www.eso.net. For further information, please
contact Francesca Marangoni (fmarangoni@eso.net)
:: 10 ::

GENERAL INFORMATION
MEDIA REGISTRATION
The congress is open to representatives of print and electronic media. Registration is free of
charge to journalists who are in possession of a valid, recognised press card. Freelance journalists
must present a commissioning letter on headed paper from a recognised news organisation or
publication. Representatives of advertising, marketing and public relations companies are not
eligible for free media registration. A copy of the Press Card or of the commissioning letter should
be sent, together with the media registration form, to
Roberta Ventura (rventura@eso.net).
CANCELLATION OF REGISTRATION OR REPLACEMENT
Cancellation should be notified to ESO in writing. In case of cancellation without replacement,
the fee less handling charges of EUR 100 will be refunded after the event, provided that the
cancellation is received by ESO before 7 October.
Replacements will be possible till 14 October 2012.
CONFIRMATION OF REGISTRATION
Registration will be confirmed by e-mail, by fax or by mail.
ACKNOWLEDGEMENTS
ESO would like to gratefully acknowledge the support and assistance from Fáilte Ireland.
Fáilte Ireland acts as a corporate resource for tourism professionals and service providers at
local, regional and national levels.
Aer Lingus is delighted to assist delegates attending the BCY1 - Breast Cancer in Young Women
Conference.
Please go to www.aerlingus.com/conference/bcy for more information on group bookings, direct flights,
connecting flights, fares and availability.
DEADLINES
Abstracts: 1 July 2012
Travel grants: 1 July 2012
Early registration: by 5 August 2012
Late registration: by 14 October 2012
On-site registration: after 14 October 2012
:: 11 ::

ACCOMMODATION FORM
BCY1 - BREAST CANCER IN YOUNG WOMEN CONFERENCE - 8-10 November 2012, Dublin, Ireland
Please fill in this form using BLOCK Capitals and send to Leah Perrot at MCI Dublin by email or fax to
esodublin@mci-group.com - Fax +353 1 2805405
MCI Dublin - 1 Clarinda North, Dun Laoghaire, Co.Dublin, Ireland - Tel +353 1 2802641
For online accommodation booking and for more information on the hotels please go to www.eso.net
PARTICIPANT INFORMATION
Dr. Prof. Mr. Ms.
First name
Organisation
Address
City
State/County
Tel
(including country code)
Surname
Postcode/Zipcode
Country
Fax
(including country code)
BOOKING
All rates are quoted in Euro, per night including breakfast and VAT.
Please choose your hotel below
Single room Double room Twin room
Stillorgan Park Hotel ( ) EUR 99 EUR 109 EUR 109
Ballsbridge Inn ( ) EUR 75 EUR 90 EUR 90
D4 Berkeley ( ) EUR 100 EUR 115 EUR 115
Check in date
Check out date
Sharing with
TERMS AND CONDITONS
Please see the online booking system on www.eso.net
CREDIT CARD DETAILS
Accommodation payment and extras will be paid directly to the hotel. Please provide your credit
card details in order to guarantee your booking. With out card details it will not be possible to
make a booking.
CREDIT CARD: Mastercard or Visa only
Credit card number / / / Expiry date /
Card holders name (in Capital letters)
CVV number
Card holders signature
I agree to the terms and conditions and that my credit card details will be forwarded to the appropriate
hotel to guarantee my booking.
Signature
If you require any assistance with your booking please do not hesitate to contact Leah Perrott at:
esodublin@mci-group.com - Tel: +353 1 2802641

REGISTRATION FORM
BCY1 - BREAST CANCER IN YOUNG WOMEN CONFERENCE - 8-10 November 2012, Dublin, Ireland
Please fill in this form in BLOCK CAPITALS and send by the deadline to:
European School of Oncology - Roberta Ventura - Via del Bollo, 4 - 20123 Milan - Italy
Tel: +39 02 8546 4532 - Fax: +39 02 8546 4545 - Email: rventura@eso.net
PARTICIPANT’S DETAILS
ONLINE REGISTRATION IS AVAILABLE AT www.eso.net
Dr. Prof.
Surname
Name
Institute
Department
Street
Zip Code Town Country
Phone Fax Mobile
Email
Date of birth
Birth place (town and country)
Profession
Specialisation
Main field
VAT number (Compulsory for all freelancers)
Fiscal Code (Italian residents only)
If your invoice details are different to those above, please complete the following section:
Invoice contact details
Address
Phone
email
VAT number (Compulsory for all freelancers)
Fiscal Code (Italian residents only)
REGISTRATION FEES:
Registration includes participation in all sessions, a copy of the Programme and the Abstract Book, coffee breaks
and lunches as indicated in the programme.
Payable in Euro Early rate Late rate On site rate
(by 5 August) (by 14 October) (after 14 October)
Registration fee EUR 350 EUR 450 EUR 550
BreastCentresNetwork Members EUR 250 EUR 450 EUR 550
Club ESO Members EUR 250 EUR 450 EUR 550
ESMO Members EUR 250 EUR 450 EUR 550
PAYMENT DETAILS:
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)
Visa/Mastercard Card Number / / /
Expire date / CV2 code
Holder’s name:
and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer):
Bank:
Account holder:
Number:
IBAN:
Reference
Banca Popolare di Milano, Agenzia 24 - Milan, Italy
European School of Oncology
No. 16333
IT96G0558401624 0000000 16333 - BIC: BPMIITM1024
“BCY1” + your name
I authorize the European School of Oncology to use my personal data according to what is specified in Article 13 DLGS 196,
available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature
Date

European School of Oncology (ESO)
Via del Bollo, 4
20123 Milan, Italy
Ph +39 02 8546451
Fx +39 02 85464545
www.eso.net
is member of